Support for the hypoxia theory in the pathogenesis of infantile haemangioma
- 16 December 2014
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 40 (4) , 431-437
Abstract
The pathogenesis of infantile haemangioma (IH) is unknown. Several mechanisms have been proposed, including hypoxia, which triggers upregulation and stabilization of hypoxia-inducible factor (HIF)1α. HIF1α stimulates downstream transcription of target genes that enhance angiogenesis.To identify possible involvement of hypoxia in the pathogenesis of IH, as hypoxia signalling constitutes a potential therapeutic target.IH tissue samples collected during the period 1991-2011 (preserved in paraffin wax) were immunohistochemically analysed for HIF1α and the known HIF1α targets: BCL2/adenovirus E1B kD-interacting protein family member 3 (BNIP3), carbon anhydrase (CA)-IX, glucose transporter (GLUT)-1, phosphorylated protein kinase B (pAKT), phosphorylated S6 protein (pS6) and vascular endothelial growth factor (VEGF). Four observers independently assessed the findings.Of the 10 IH samples, 2 appeared to be in the growth phase. In all samples, GLUT-1, BNIP3, pAKT and VEGF were positive, CA-IX was weakly positive, and HIF1α was negative. pS6 was positive in 9/10 cases and negative in 1/10.Several factors implicated in hypoxia-induced angiogenesis may be involved in IH development. However, the small sample size and retrospective approach of the study preclude definitive conclusions. Prospective studies are needed to conclusively determine which of the factors involved in the (hypoxia) cascade are required for an IH to grow, and could thus be a possible target of drugs for IH treatment.Keywords
Funding Information
- MvS is supported by GROW, School for Oncology and Developmental Biology and by A*STAR, Agency for Science, Technology and Research, Singapore
- TB is supported by a grant from KWF Kankerbestrijding (Dutch Cancer Society) (UM 2009-4605)
This publication has 24 references indexed in Scilit:
- Rapamycin Inhibits Proliferation of Hemangioma Endothelial Cells by Reducing HIF-1-Dependent Expression of VEGFPLOS ONE, 2012
- Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile HemangiomaJournal of Investigative Dermatology, 2011
- PI3K/AKT/mTOR Pathway in AngiogenesisFrontiers in Molecular Neuroscience, 2011
- Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatmentEuropean Journal of Cancer, 2010
- Update on vascular tumors of infancyCurrent Opinion in Pediatrics, 2010
- Corticosteroid Suppression of VEGF-A in Infantile Hemangioma-Derived Stem CellsNew England Journal of Medicine, 2010
- Placental hypoxia and neonatal haemangioma: clinical and histological observationsBritish Journal of Dermatology, 2009
- Current Theories on the Pathogenesis of Infantile HemangiomaSeminars in Ophthalmology, 2009
- Myeloid Cells in Infantile HemangiomaThe American Journal of Pathology, 2006
- The HIF-2α/VEGF pathway activation in cutaneous capillary haemangiomasPathology, 2005